OB/GYN Clinical Alert
RSSArticles
-
Perinatal Outcomes in Twins: The Effect of Placental Abruption
Birth weight discordancy of > 15% for same sex and > 30% for different sex confer greatest risk of adverse perinatal outcomes in the absence of abruption. -
Relationship Between Long Durations and Different Regimenes of Hormone Therapy and Risk of Brest Cancer
The data in this case-control study of combined estrogen plus progestin therapy revealed an increased risk of breast cancer, particularly invasive lobular tumor, regardless of whether the progestin component was taken sequentially or continuously. -
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women
In an intent-to-treat analysis, the use of conjugated equine estrogen combined with continuous medroxyprogesterone acetate by menopausal women increased the hazard ratio of invasive breast cancer to 1.24. -
Clinical Briefs in Primary Care Supplement
-
Clinical Briefs in Primary Care Supplement
-
Special Offer to Subscribers
-
Ethnicity and Insulin Resistance
Insulin resistance increases with increasing body weight and is most prevalent in Mexican-Americans. -
Three More Reports from the WHI
One year after the cancelation of the estrogen-progestin arm of the WHI, 3 more reports have emerged from this landmark study. Leon Speroff, MD, and Sarah L. Berga, MD provide their analysis. -
‘Tamponade Test’ in the Management of Massive Postpartum Hemorrhage
This diagnostic test rapidly identifies those patients with postpartum hemorrhage who will require a laparotomy. Even when results are positive, life-threatening hemorrhage is arrested and time is also allowed to correct any consumptive coagulopathy. -
Pharmacology Watch: HRT, Estrogen, and Postmenopausal Women: Year-Old WHI Study Continues to Raise Questions